How Ozempic And Wegovy Accidentally Made Novo Nordisk A $400B Company
October 9, 2023
282,235
2,883
650
1.25%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Cnbc Episodes Around October 9, 2023
See what was published immediately before and after this episode.
Chapters
YouTube Description
as posted by the channelPharmaceutical giant, Novo Nordisk, is now Europe’s most valuable company, worth more than its home country, Denmark’s total economy. That wasn’t always the case, and only recently, through its popular diabetes and weight-loss drugs, Ozempic and Wegovy, is it witnessing unprecedented financial success. For a century, the company predominantly focused on insulin and treating those with Type 2 diabetes. In its 2023 second quarter, the company reported a 46% increase in net profits and a 32% increase in sales compared to the same quarter the year prior. Alongside competitors like Eli Lilly the company is hoping to help treat the 1 billion people worldwide who are affected by obesity and hence transform a largely untapped market.
Chapters:
Produced, shot and edited by: Natalie Rice
Narration by: Emily Lorsch
Animation by: Alex Wood, Christina Locopo
Senior Managing Producer: Tala Hadavi
Denmark Producer: Mary Hanan
Additional Camera: Alex Herrera, Gerry Miller, Marco Mastrorilli, Angela Neil, Adam Galica, Eric Hanan
Audio by: Neil Munroe, Mark Roberts
Additional footage: CNBC International, Novo Nordisk, Getty Images, Reuters, Moderna, AP Images
Additional editorial support by: Melissa Lee
» Subscribe to CNBC TV
» Subscribe to CNBC
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
Get the latest news
Follow CNBC on LinkedIn
Follow CNBC News on Facebook
Follow CNBC News on Twitter
Follow CNBC News on Instagram
#CNBC
#CNBCTV
How Ozempic And Wegovy Accidentally Made Novo Nordisk A $400B Company
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.